Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 1

Effects and mechanisms of curcumin on the hemodynamic variables of isolated perfused rat hearts

Pages
166–173
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our results suggest that curcumin produces dose-dependent negative chronotropic and inotropic effects in isolated perfused rat hearts.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: There is no information on the dose response relationship of curcumin on the hemodynamic variables of the heart at the organ level in isolated perfused rat hearts.
📊
Key Findings & Data:Materials and methods: Rats were randomly divided into 9 groups.
💡
Conclusion & Impact:Conclusion: Our results suggest that curcumin produces dose-dependent negative chronotropic and inotropic effects in isolated perfused rat hearts.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: There is no information on the dose response relationship of curcumin on the hemodynamic variables of the heart at the organ level in isolated perfused rat hearts. We aimed to investigate the effects and mechanisms of curcumin on the hemodynamic variables of isolated perfused rat hearts. Materials and methods: Rats were randomly divided into 9 groups. The isolated rat heart was retrogradely perfused with modified Krebs Henseleit solution. After the stabilization period, each group was administered one of the following treatments for 25 min: saline, dimethyl sulfoxide, and curcumin (0.2 µM, 1 µM, and 5 µM); atropine (1 µM); atropine (1 µM) + curcumin (1 µM); L-NAME (100 µM); or L-NAME (100 µM) + curcumin (1 µM). Hemodynamic variables of the heart were measured. Results: Curcumin at dose of 1 µM decreased the heart rate (from 271 ± 11.1 to 200.4 ± 14.3 beats/min, P = 0.011) but increased enddiastolic pressure (from 7.0 ± 0.4 to 54.6 ± 7.9 mmHg, P = 0.0008). A dose of 5 µM curcumin caused a decrease in the developed pressure (from 87.58 ± 9.0 to 65.40 ± 7.0 mmHg, P = 0.047) but an increase in the end-diastolic pressure (from 6.8 ± 0.6 to 48.9 ± 7.7 mmHg, P = 0.005). Atropine (1 µM) reversed the effects of curcumin on the heart. Conclusion: Our results suggest that curcumin produces dose-dependent negative chronotropic and inotropic effects in isolated perfused rat hearts.

🔖

Cite This Article

KILINÇ, E., GÜMÜŞTEKİN, K., KAYGISIZ, Z., BENEK, B. S. (2022). Effects and mechanisms of curcumin on the hemodynamic variables of isolated perfused rat hearts. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 1, 166–173. https://ajindex.com/articles/610675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006; 78: 2081–2087
  2. Srivastava G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol Ther 2009; 1: 22–27
  3. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol 2008; 75: 787–809
  4. Swamy AV, Gulliaya S, Thippeswamy A, Koti BC, Manjula DV. Cardioprotective effect of curcumin against doxorubicininduced myocardial toxicity in albino rats. Indian J Pharmacol 2012; 1: 73–77
  5. Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, Puvanakrishnan R. Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol 2004; 36: 1967–1980
  6. Srivastava R, Dikshit M, Srimal RC, Dhawan BN. Antithrombotic effect of curcumin. Thromb Res 1985; 40: 413–417
  7. Li HL, Liu C, De Couto G, Ouzounian M, Sun M, Wang AB, Huang Y, He CW, Shi Y, Chen X et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008; 118: 879–893
  8. Nirmala C, Puvanakrishnan R. Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. Biochem Pharmacol 1996; 51: 47–51
  9. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 1998; 124: 425–427
  10. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of not-so-lone atrial fibrillation. Europace 2008; 10: 668–673
  11. Quiles JL, Mesa MD, Ramírez-Tortosa CL, Aguilera CM, Battino M, Gil A. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002; 22: 1225–1231
  12. Bronte E, Coppola G, Di Miceli R, Sucato V, Russo A, Novo S. Role of curcumin in idiopathic pulmonary arterial hypertension treatment: a new therapeutic possibility. Med Hypotheses 2013; 81: 923–926
  13. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10: 6847–6854
  14. Kaygısız Z, Kaygısız B, Kılınç E. The effect of Des-Arg9- bradykinin and bradykinin-potentiating peptide C on isolated rat hearts. Acta Physiol Hung 2013; 100: 280–288
  15. Deng XF, Mulay S, Chemtob S, Varma DR. Mechanisms of the atrium-s